Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home
 

Online Report Subscribers, Click Here
Pricing and Ordering Information

  

United Kingdom, Disease Incidence and Prevalence
Report #A709 - October 2012
342 Pages – 97 Exhibits

As the aging population in Europe increases and the average life span lengthens, the incidence and prevalence of major diseases/disorders are expected to significantly impact the European healthcare industry. This dynamic new report from Medtech Insight examines the incidence and prevalence of selected diseases/ disorders in the United Kingdom (U.K.) and compares them with those of the Benelux countries (Belgium, Luxembourg, and the Netherlands), the Nordic countries (Denmark, Finland, Norway, and Sweden), and the European Union (Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, and the U.K.).

This report is the final in a series of five reports (Disease Incidence and Prevalence for France, Germany, Italy, Spain, and the U.K.) that examine the etiology and epidemiology of the most prevalent and costly diseases/disorders in Europe. Topics covered by each of these reports include Alzheimer’s disease, anemia, arthritis, asthma, benign prostatic hyperplasia, bronchitis, burns/traumatic wounds, cancer, depression, diabetes, emphysema, erectile dysfunction, glaucoma, heart failure, human immunodeficiency virus/acquired immune deficiency syndrome, hypertension, infertility, multiple sclerosis, osteoporosis, pneumonia, stroke, and transmissible spongiform encephalopathies, among others.

In addition to proprietary data utilized from Medtech Insight’s internal resources, many agencies and organizations have provided information including Alzheimer’s Disease International, Asthma UK, AVM Support UK, Bipolar UK (the working name of Manic Depression Fellowship [MDF] The Bipolar Organisation), the British Snoring & Sleep Apnoea Association, Cystic Fibrosis Europe, Epilepsy Action/British Epilepsy Association and the Joint Epilepsy Council of the U.K. and Ireland, European Association of Urology, European Cancer Observatory, European Centre for Disease Prevention and Control, European Haemophilia Consortium, European Kidney Health Alliance, European Respiratory Society, European Society of Cardiology, Infertility Network UK, International Diabetes Federation, International Glaucoma Association, International Osteoporosis Foundation, Lung & Asthma Information Agency/St. George’s University of London, Multiple Sclerosis International Federation, Myasthenia Gravis Association, Organization for Economic Cooperation and Development, the Schizophrenia Association of Great Britain, World Endometriosis Research Foundation, and the World Health Organization, among others.

Ordering Information

Title

 Report# Publication
Date		 List Price

United Kingdom, Disease Incidence and Prevalence

A709

October 2012

$4,850
Order Online:
Single User only (Please call for corporate subscription pricing)		 PDF Only

Print versions of Reports are available upon request for an additional fee.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

 

TABLE OF CONTENTS

 

INTRODUCTION

 

1. EUROPEAN HEALTHCARE OVERVIEW

1.1 Healthcare Spending

1.2 Healthcare Facilities and Providers

1.3 Reimbursement Structures and Common Market Directives

1.4 Selected National Healthcare Profiles for the United Kingdom

1.4.1 Healthcare Organization and Reform

1.4.2 Hospital/Medical Services and Reimbursement

1.4.3 Medical Device Reimbursement

 

Exhibit 1-1:      European Healthcare Expenditures as a Percentage of Gross Domestic Product, Selected Countries, 2002-2008

Exhibit 1-2:      European Union Population Statistics Comparison for the Years 2000, 2010, and 2020

Exhibit 1-3:      Classification of European Healthcare Providers

Exhibit 1-4:      Healthcare Providers within the European Economy

Exhibit 1-5:      Average Hospital Length of Stay, Acute Care, Selected Countries, 2002-2008

Exhibit 1-6:      European Union, Medical Devices Risk Classification System

Exhibit 1-7:      United Kingdom, Selected National Healthcare Statistics

 

2. BLOOD DISORDERS: ANEMIA AND HEMOPHILIA

2.1 Anemia

2.1.1 Iron Deficiency Anemia

2.1.1.1 Etiology

2.1.1.2 Epidemiology

2.1.2 Sickle Cell Anemia

2.1.2.1 Etiology

2.1.2.2 Epidemiology

2.1.3 Thalassemia

2.1.3.1 Etiology

2.1.3.2 Epidemiology

2.2 Hemophilia

2.2.1 Etiology

2.2.2 Epidemiology

 

Exhibit 2-1:      Europe, Estimated Prevalence of Anemia, by Age and Gender

Exhibit 2-2:      United Kingdom and Europe, Iron Deficiency Anemia, Comparative Incidence and Prevalence

Exhibit 2-3:      United Kingdom and Europe, Sickle Cell Anemia, Comparative Incidence and Prevalence

Exhibit 2-4:      United Kingdom and Europe, Thalassemia, Comparative Prevalence

Exhibit 2-5:      United Kingdom and Europe, Hemophilia, Comparative Incidence and Prevalence

 

3. CANCER

3.1 Bladder Cancer

3.1.1 Etiology

3.1.2 Epidemiology

3.2 Brain Tumors

3.2.1 Etiology

3.2.2 Epidemiology

3.3 Breast Cancer

3.3.1 Etiology

3.3.2 Epidemiology

3.4 Cervical/Uterine Cancer

3.4.1 Etiology

3.4.2 Epidemiology

3.5 Colon/Rectal Cancer

3.5.1 Etiology

3.5.2 Epidemiology

3.6 Esophageal Cancer

3.6.1 Etiology

3.6.2 Epidemiology

3.7 Kidney/Urothelial Cancer

3.7.1 Etiology

3.7.2 Epidemiology

3.8 Leukemia

3.8.1 Etiology

3.8.2 Epidemiology

3.9 Lung Cancer

3.9.1 Etiology

3.9.2 Epidemiology

3.10 Lymphoma

3.10.1 Etiology

3.10.2 Epidemiology

3.11 Melanoma

3.11.1 Etiology

3.11.2 Epidemiology

3.12 Oral Cancer

3.12.1 Etiology

3.12.2 Epidemiology

3.13 Ovarian Cancer

3.13.1 Etiology

3.13.2 Epidemiology

3.14 Pancreatic Cancer

3.14.1 Etiology

3.14.2 Epidemiology

3.15 Prostate Cancer

3.15.1 Etiology

3.15.2 Epidemiology

3.16 Stomach Cancer

3.16.1 Etiology

3.16.2 Epidemiology

3.17 Testicular Cancer

3.17.1 Etiology

3.17.2 Epidemiology

 

Exhibit 3-1:      United Kingdom and Europe, Bladder Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-2:      United Kingdom and Europe, Brain Tumors, Comparative Incidence, by Gender

Exhibit 3-3:      United Kingdom and Europe, Breast Cancer, Comparative Incidence and Mortality

Exhibit 3-4:      United Kingdom and Europe, Cervical/Uterine Cancer, Comparative Incidence and Mortality

Exhibit 3-5:      United Kingdom and Europe, Colon/Rectal Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-6:      United Kingdom and Europe, Esophageal Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-7:      United Kingdom and Europe, Kidney/Urothelial Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-8:      United Kingdom and Europe, Leukemia, Comparative Incidence and Mortality, by Gender

Exhibit 3-9:      United Kingdom and Europe, Lung Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-10:    United Kingdom and Europe, Lymphoma, Comparative Incidence and Mortality, by Gender

Exhibit 3-11:    United Kingdom and Europe, Melanoma, Comparative Incidence and Mortality, by Gender

Exhibit 3-12:    United Kingdom and Europe, Oral Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-13:    United Kingdom and Europe, Ovarian Cancer, Comparative Incidence and Mortality

Exhibit 3-14:    United Kingdom and Europe, Pancreatic Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-15:    United Kingdom and Europe, Prostate Cancer, Comparative Incidence and Mortality

Exhibit 3-16:    United Kingdom and Europe, Stomach Cancer, Comparative Incidence and Mortality, by Gender

Exhibit 3-17:    United Kingdom and Europe, Testicular Cancer, Comparative Incidence and Mortality

 

4. CARDIOVASCULAR DISORDERS

4.1 Cardiac Arrhythmia

4.1.1 Etiology

4.1.2 Epidemiology

4.2 Heart Failure

4.2.1 Etiology

4.2.2 Epidemiology

4.3 Heart Valve Disorders

4.3.1 Etiology

4.3.2 Epidemiology

4.4 Hypertension

4.4.1 Etiology

4.4.2 Epidemiology

4.5 Vascular Disorders

4.5.1 Aneurysms

4.5.1.1 Etiology

4.5.1.2 Epidemiology

4.5.2 Angina Pectoris

4.5.2.1 Etiology

4.5.2.2 Epidemiology

4.5.3 Atherosclerosis

4.5.3.1 Etiology

4.5.3.2 Epidemiology

4.5.4 Myocardial Infarction

4.5.4.1 Etiology

4.5.4.2 Epidemiology

4.5.5 Peripheral Vascular Disease

4.5.5.1 Etiology

4.5.5.2 Epidemiology

 

Exhibit 4-1:      United Kingdom and Europe, Atrial Fibrillation, Comparative Incidence and Prevalence

Exhibit 4-2:      United Kingdom and Europe, Atrial Flutter, Comparative Incidence and Prevalence

Exhibit 4-3:      United Kingdom and Europe, Supraventricular Tachycardia, Comparative Incidence and Prevalence

Exhibit 4-4:      United Kingdom and Europe, Heart Failure, Comparative Incidence and Prevalence, by Gender

Exhibit 4-5:      United Kingdom and Europe, Heart Valve Disorders, Comparative Incidence and Prevalence, by Gender

Exhibit 4-6:      United Kingdom and Europe, Hypertension, Comparative Incidence and Prevalence

Exhibit 4-7:      United Kingdom and Europe, Aneurysms, Comparative Incidence and Prevalence

Exhibit 4-8:      Standard Angina Pectoris Classification

Exhibit 4-9:      United Kingdom and Europe, Angina Pectoris, Comparative Incidence and Prevalence, by Gender

Exhibit 4-10:    United Kingdom and Europe, Hypercholesteremia, Comparative Prevalence, by Gender and Selected Country

Exhibit 4-11:    United Kingdom and Europe, Myocardial Infarction, Comparative Incidence and Prevalence, by Gender

Exhibit 4-12:    United Kingdom and Europe, Peripheral Vascular Disease, Comparative Incidence and Prevalence

 

5. METABOLIC DISORDERS

5.1 Cholelithiasis

5.1.1 Etiology

5.1.2 Epidemiology

5.2 Chronic Kidney Disease/End-Stage Renal Disease

5.2.1 Etiology

5.2.2 Epidemiology

5.3 Diabetes

5.3.1 Etiology

5.3.2 Epidemiology

5.4 Urolithiasis

5.4.1 Etiology

5.4.2 Epidemiology

 

Exhibit 5-1:      United Kingdom and Europe, Cholelithiasis, Comparative Incidence and Prevalence

Exhibit 5-2:      United Kingdom and Europe, Chronic Kidney Disease, Comparative Incidence and Prevalence, by Gender

Exhibit 5-3:      United Kingdom and Europe, Diabetes, Comparative Incidence, by Gender

Exhibit 5-4:      United Kingdom and Europe, Diabetes, Comparative Prevalence, by Share of Population

Exhibit 5-5:      United Kingdom and Europe, Diabetes, Comparative Prevalence, by Gender and Age Group

Exhibit 5-6:      United Kingdom and Europe, Urolithiasis, Comparative Incidence and Prevalence

 

6. MUSCULOSKELETAL DISORDERS

6.1 Arthritis

6.1.1 Etiology

6.1.2 Epidemiology

6.2 Carpal Tunnel Syndrome

6.2.1 Etiology

6.2.2 Epidemiology

6.3 Meniscal and Ligament/Tendon Injuries

6.3.1 Etiology

6.3.2Epidemiology

6.4Duchenne Muscular Dystrophy

6.4.1 Etiology

6.4.2 Epidemiology

6.5 Osteoporosis

6.5.1 Etiology

6.5.2 Epidemiology

 

Exhibit 6-1:      United Kingdom and Europe, Rheumatoid Arthritis, Comparative Incidence and Prevalence

Exhibit 6-2:      United Kingdom and Europe, Osteoarthritis of the Knee, Comparative Incidence and Prevalence

Exhibit 6-3:      United Kingdom and Europe, Osteoarthritis of the Hip, Comparative Incidence and Prevalence

Exhibit 6-4:      United Kingdom and Europe, Carpal Tunnel Syndrome, Comparative Incidence and Prevalence

Exhibit 6-5:      United Kingdom and Europe, Meniscal and Ligament/Tendon Injuries of the Knee, Comparative Incidence and Prevalence

Exhibit 6-6:      United Kingdom and Europe, Duchenne Muscular Dystrophy, Comparative Incidence and Prevalence

Exhibit 6-7:      United Kingdom and Europe, Osteoporosis, Comparative Incidence and Prevalence

 

7. NEUROLOGIC AND PSYCHIATRIC DISORDERS

7.1 Alzheimer’s Disease and Dementia

7.1.1 Etiology

7.1.2 Epidemiology

7.2 Amyotrophic Lateral Sclerosis

7.2.1 Etiology

7.2.2 Epidemiology

7.3 Bipolar Disorder

7.3.1 Etiology

7.3.2 Epidemiology

7.4 Cerebrovascular Disorders

7.4.1 Arteriovenous Malformation

7.4.1.1 Etiology

7.4.1.2 Epidemiology

7.4.2 Stroke

7.4.2.1 Etiology

7.4.2.2 Epidemiology

7.5 Depression

7.5.1 Etiology

7.5.2 Epidemiology

7.6 Epilepsy

7.6.1 Etiology

7.6.2 Epidemiology

7.7 Huntington’s Disease

7.7.1 Etiology

7.7.2 Epidemiology

7.8 Hydrocephalus

7.8.1 Etiology

7.8.2 Epidemiology

7.9 Multiple Sclerosis

7.9.1 Etiology

7.9.2 Epidemiology

7.10 Myasthenia Gravis

7.10.1 Etiology

7.10.2 Epidemiology

7.11 Parkinson’s Disease

7.11.1 Etiology

7.11.2 Epidemiology

7.12 Schizophrenia

7.12.1 Etiology

7.12.2 Epidemiology

 

Exhibit 7-1:      2010, Europe, Diagnosed and Undiagnosed Dementia, Incidence Rates, by Age and Gender

Exhibit 7-2:      2010, Europe, Diagnosed and Undiagnosed Dementia, Prevalence Rates, by Age and Gender

Exhibit 7-3:      United Kingdom and Europe, Alzheimer’s Disease, Comparative Incidence and Prevalence

Exhibit 7-4:      United Kingdom and Europe, Amyotrophic Lateral Sclerosis, Comparative Incidence and Prevalence

Exhibit 7-5:      United Kingdom and Europe, Bipolar Disorder, Comparative Incidence and Prevalence

Exhibit 7-6:      United Kingdom and Europe, Arteriovenous Malformation, Comparative Incidence and Prevalence

Exhibit 7-7:      United Kingdom and Europe, Stroke, Comparative Incidence and Prevalence

Exhibit 7-8:      United Kingdom and Europe, Depression, Comparative Prevalence

Exhibit 7-9:      United Kingdom and Europe, Epilepsy, Comparative Incidence and Prevalence

Exhibit 7-10:    United Kingdom and Europe, Huntington’s Disease, Comparative Incidence and Prevalence

Exhibit 7-11:    United Kingdom and Europe, Hydrocephalus, Comparative Incidence and Prevalence

Exhibit 7-12:    United Kingdom and Europe, Multiple Sclerosis, Comparative Incidence and Prevalence

Exhibit 7-13:    United Kingdom and Europe, Myasthenia Gravis, Comparative Incidence and Prevalence

Exhibit 7-14:    United Kingdom and Europe, Parkinson’s Disease, Comparative Incidence and Prevalence

Exhibit 7-15:    United Kingdom and Europe, Schizophrenia, Comparative Incidence and Prevalence

 

8. OPHTHALMIC DISORDERS: CATARACTS AND GLAUCOMA

8.1 Cataracts

8.1.1 Etiology

8.1.2 Epidemiology

8.2 Glaucoma

8.2.1 Etiology

8.2.2 Epidemiology

 

Exhibit 8-1:      United Kingdom and Europe, Cataracts, Comparative Incidence and Prevalence

Exhibit 8-2:      United Kingdom and Europe, Glaucoma, Comparative Incidence and Prevalence

 

9. REPRODUCTIVE AND GENITOURINARY DISORDERS

9.1 Benign Prostatic Hyperplasia

9.1.1 Etiology

9.1.2 Epidemiology

9.2 Endometriosis

9.2.1 Etiology

9.2.2 Epidemiology

9.3 Erectile Dysfunction

9.3.1 Etiology

9.3.2 Epidemiology

9.4 Infertility

9.4.1 Etiology

9.4.2 Epidemiology

9.5 Urinary Incontinence

9.5.1 Etiology

9.5.2 Epidemiology

 

Exhibit 9-1:      2010, Europe, Benign Prostatic Hyperplasia, Incidence, by Age

Exhibit 9-2:      United Kingdom and Europe, Benign Prostatic Hyperplasia, Comparative Incidence and Prevalence

Exhibit 9-3:      United Kingdom and Europe, Endometriosis, Comparative Prevalence

Exhibit 9-4:      United Kingdom and Europe, Erectile Dysfunction, Comparative Incidence and Prevalence

Exhibit 9-5:      United Kingdom and Europe, Infertility, Comparative Incidence and Prevalence

Exhibit 9-6:      United Kingdom and Europe, Urinary Incontinence, Comparative Incidence and Prevalence

 

10. RESPORATORY DISORDERS

10.1 Acute Respiratory Distress Syndrome

10.1.1 Etiology

10.1.2 Epidemiology

10.2 Apnea

10.2.1 Etiology

10.2.2 Epidemiology

10.3 Asthma

10.3.1 Etiology

10.3.2 Epidemiology

10.4 Cystic Fibrosis

10.4.1 Etiology

10.4.2 Epidemiology

10.5 Emphysema

10.5.1 Etiology

10.5.2 Epidemiology

10.6 Pneumothorax

10.6.1 Etiology

10.6.2 Epidemiology

10.7 Respiratory Failure

10.7.1 Etiology

10.7.2 Epidemiology

10.8 Restrictive Lung Disease

10.8.1 Etiology

10.8.2 Epidemiology

 

Exhibit 10-1:    United Kingdom and Europe, Acute Respiratory Distress Syndrome, Comparative Incidence

Exhibit 10-2:    United Kingdom and Europe, Apnea, Comparative Incidence and Prevalence

Exhibit 10-3:    United Kingdom and Europe, Asthma, Comparative Incidence and Prevalence

Exhibit 10-4:    United Kingdom and Europe, Cystic Fibrosis, Comparative Incidence and Prevalence

Exhibit 10-5:    United Kingdom and Europe, Emphysema, Comparative Prevalence

Exhibit 10-6:    United Kingdom and Europe, Pneumothorax, Comparative Incidence and Prevalence

Exhibit 10-7:    United Kingdom and Europe, Respiratory Failure, Comparative Incidence and Prevalence

Exhibit 10-8:    United Kingdom and Europe, Restrictive Lung Disease, Comparative Incidence and Prevalence

 

11. WOUNDS

11.1 Diabetic Ulcers

11.1.1 Etiology

11.1.2 Epidemiology

11.2 Pressure Ulcers

11.2.1 Etiology

11.2.2 Epidemiology

11.3 Surgical Wounds

11.3.1 Etiology

11.3.2 Epidemiology

11.4 Traumatic Wounds

11.4.1 Burns

11.4.2 Head Injuries, Lacerations, Contusions, and Abrasions

 

Exhibit 11-1:    United Kingdom and Europe, Diabetic Ulcers, Comparative Incidence and Prevalence

Exhibit 11-2:    United Kingdom and Europe, Pressure Ulcers, Comparative Incidence and Prevalence

Exhibit 11-3:    United Kingdom and Europe, Surgical Wounds, Comparative Incidence

Exhibit 11-4:    Classification of Burns, by Mechanism of Injury

Exhibit 11-5:    United Kingdom and Europe, Burns and Acute Traumatic Injury, Comparative Incidence

 

 

12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS

12.1 Chronic Bronchitis

12.1.1 Etiology

12.1.2 Epidemiology

12.2 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome

12.2.1 Etiology

12.2.2 Epidemiology

12.3 Pneumonia

12.3.1 Etiology

12.3.2 Epidemiology

12.4 Transmissible Spongiform Encephalopathies

12.4.1 Etiology

12.4.2 Epidemiology

12.5 Tuberculosis

12.5.1 Etiology

12.5.2 Epidemiology

 

Exhibit 12-1:    United Kingdom and Europe, Chronic Bronchitis, Comparative Prevalence

Exhibit 12-2:    Acquired Immune Deficiency Syndrome, Indicator Disease

Exhibit 12-3:    United Kingdom and Europe, Human Immunodeficiency Virus, Comparative Incidence and Prevalence

Exhibit 12-4:    United Kingdom and Europe, Acquired Immune Deficiency Syndrome, Comparative Incidence and Prevalence

Exhibit 12-5:    United Kingdom and Europe, Pneumonia, Comparative Incidence

Exhibit 12-6:    United Kingdom and Europe, Transmissible Spongiform Encephalopathies, Comparative Incidence

Exhibit 12-7:    United Kingdom and Europe, Tuberculosis, Comparative Incidence and Prevalence

 

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@elsevier.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.

 

The Newsletter | The Principals | Reports | Conferences | Physician Surveys | Consulting | Contact Us | Home